MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 16.08.2022
Global Cord Blood Corporation EBITDA per Share 2011-2026 | CO
EBITDA per Share Jährlich Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.37 | 4.85 | 4.97 | 3.57 | 2.77 | 4.28 | 3.19 | 3.91 | 3.68 | 3.43 | 2.22 | 2.1 |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.37 | 2.1 | 3.7 |
EBITDA per Share Vierteljährlich Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.41 | - | - | - | 1.24 | - | - | - | 1.28 | - | - | - | 0.97 | - | - | - | 0.77 | - | - | - | 0.91 | - | - | - | 0.88 | - | - | - | 0.95 | - | - | - | 0.87 | 0.63 | - | - | 0.78 | 0.61 | 0.48 | 0.43 | 0.59 | - | 0.48 |
Alle Zahlen in CNY-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.41 | 0.43 | 0.83 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
5.49 | $ 119.04 | - | $ 36.2 B |  USA |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.83 | - | $ 91.8 K | USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 23.54 | - | $ 247 M |  China |
 |
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 27.57 | - | $ 766 M | USA |
 |
Celcuity
CELC
|
-2.87 | $ 107.4 | - | $ 4.24 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 13.79 | - | $ 417 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 175.69 | - | $ 8.71 B | USA |
 |
IDEXX Laboratories
IDXX
|
18.7 | $ 635.54 | - | $ 51.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 129.56 | - | $ 20.6 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 282.99 | - | $ 23.5 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 78.84 | - | $ 5.32 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-0.22 | $ 15.5 | - | $ 2.01 B | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 316.71 | - | $ 27.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 5.29 | - | $ 490 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.54 | - | $ 1.22 B | USA |
 |
BioNano Genomics
BNGO
|
-70.8 | $ 1.12 | - | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 208.36 | - | $ 23.1 B | USA |
 |
National Research Corporation
NRC
|
1.64 | $ 13.39 | - | $ 329 M | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 204.01 | - | $ 145 B | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | $ 103.37 | - | $ 19.5 B | USA |
 |
OPKO Health
OPK
|
-0.08 | $ 1.19 | - | $ 826 M | USA |
 |
Bioventus
BVS
|
-0.39 | $ 8.74 | - | $ 548 M | USA |
 |
DarioHealth Corp.
DRIO
|
-1.96 | $ 10.3 | -4.19 % | $ 292 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.52 | - | $ 456 M | USA |
 |
DexCom
DXCM
|
2.98 | $ 73.08 | - | $ 28.5 B | USA |
 |
PerkinElmer
PKI
|
6.54 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
-0.21 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.35 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 108.7 | - | $ 8.97 B |  Irlanda |
 |
Quotient Limited
QTNT
|
-0.806 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
-4.93 | $ 24.98 | 1.2 % | $ 32.4 M | USA |
 |
Renalytix AI plc
RNLX
|
-0.27 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 18.8 | - | $ 1 B | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.83 | - | $ 285 M | USA |